Associated Papers
The novel curcumin analogue AKT-100 targets mutant p53 in gynecologic cancer cells.
Williams GL et al.
Biorxiv : the Preprint Server for Biology, 2025
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies.
Shen J et al.
Medcomm, 2023
Select a paper to view details